Patient | Sex | Ethnicity | Variant 1 | Variant 2 | Pace of progression | Onset | Serum creatine kinase | Weakness | Respiratory insufficiency | Referred for treatment |
---|---|---|---|---|---|---|---|---|---|---|
3 | Male | German | c.2331 + 2 T > A | c.-32-13 T > G | Slow progression | Young adult | Increased less than 10× | Yes | No | Yes |
5 | Male | Romanian | c.2066_2070dupAGCCG | c.-32-13 T > G | Slow progression | Middle age | Increased more than 10× | Yes | No | Yes |
7 | Female | Serbian | c.2269C > T | c.-32-13 T > G | Slow progression | Middle age | Increased less than 10× | Yes | No | No |
8 | Female | Serbian | c.2051C > G | c.-32-13 T > G | Slow progression | Late onset | Normal | Yes | No | No |
17 | Male | Caucasian | c.1192delC | c.2716G > A | Progressive | Young adult | Normal | Yes | Yes | Yes (now ceased) |
18 | Female | White British | c.525delT | c.-32-13 T > G | Slow progression | Middle age | Increased more than 10× | Yes | No | Yes |
32 | Male | Caucasian | c.525delT | c.-32-13 T > G | Non-progressive | Childhood | Increased less than 10× | No | No | Yes |
35 | Male | Caucasian | c.569G > A | c.2020C > G | Progressive | Young adult | Increased less than 10× | Yes | No | Yes |